Caplacizumab reduces the frequency of major thromboembolic...

  • Main
  • 2017 / 04
  • Caplacizumab reduces the frequency of major thromboembolic...
Journal of Thrombosis and Haemostasis 2017 / 04

Caplacizumab reduces the frequency of major thromboembolic events, exacerbations, and death in patients with acquired thrombotic thrombocytopenic purpura

Peyvandi, F., Scully, M., Kremer Hovinga, J. A., Knöbl, P., Cataland, S., De Beuf, K., Callewaert, F., De Winter, H., Zeldin, R. K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.13716
Date:
April, 2017
File:
PDF, 679 KB
english, 2017
Conversion to is in progress
Conversion to is failed